CEDAR KNOLLS, N.J.,
Oct. 22, 2019 /PRNewswire/ -- MYOS
RENS Technology, Inc. ("MYOS" or "the Company") (NASDAQ: MYOS),
announced today that its Chief Executive Officer, Joseph Mannello, will deliver remarks on Myos
Canine Muscle Formula®, the Company's fast-growing
Fortetropin-based veterinary product, at the New York Vet Show on
Friday, November 8th at 12:30pm, at Innovation Showcase 1 in the Javits
Center. Over the last 2 years, the New York Vet Show has provided
veterinary healthcare professionals with practical and relevant
educational, training and networking opportunities, hosting over
200 exhibitors and over 2,000 delegates each year.
![(PRNewsfoto/MYOS RENS Technology) (PRNewsfoto/MYOS RENS Technology)](https://mma.prnewswire.com/media/656707/MYOS_RENS_Technology_Logo.jpg)
Myos Canine Muscle Formula is a revolutionary
formula made to support optimal muscle health in dogs and contains
a single all-natural ingredient– Fortetropin®.
Fortetropin is made from fertilized egg yolk via a patented low
temperature technology that preserves its biological integrity and
bioactivity. Veterinary clinical research conducted at Kansas
State University College of Veterinary
Medicine, showed that the product significantly improved
recovery from injury and surgery and minimized disuse atrophy. The
product has been especially beneficial to aging dogs to improve
their mobility, vitality and quality of life. For more
information, please visit www.myospet.com
Please visit Booth #885 to learn about Myos Canine Muscle
Formula. To register for the New York Vet Show, please visit
https://newyork.vetshow.com.
About MYOS RENS Technology Inc.
MYOS RENS
Technology Inc. (MYOS), "The Muscle Company®", is a
Cedar Knolls, NJ-based advanced
nutrition company that develops and markets products that improve
muscle health and performance. MYOS is the owner of Fortetropin®, a
fertilized egg yolk-based product manufactured via a proprietary
process to retain and optimize its biological activity. Fortetropin
has been clinically shown to increase muscle size and lean body
mass in conjunction with resistance training. MYOS believes
Fortetropin has the potential to redefine existing standards of
physical health and wellness. For more information, please
visit www.myosrens.com.
About Myos Canine Muscle Formula®
Myos
Canine Muscle Formula is an advanced veterinary health supplement
to support muscle health in dogs, featuring Fortetropin as the
active ingredient. Fortetropin is made through a patented process
that maintains the vital nutrients of fertilized egg yolks to help
build more lean muscle and decrease muscle loss. For more
information, please visit www.myospet.com.
Forward-Looking Statements
Any statements in
this release that are not historical facts are forward-looking
statements. Actual results may differ materially from those
projected or implied in any forward-looking statements. Such
statements involve risks and uncertainties, including but not
limited to those relating to product and customer demand, market
acceptance of our products, the ability to create new products
through research and development, the successful results of
strategic initiatives, the success of our products,
including Qurr®, Yolked®
MYOS Canine Muscle Formula® and MYOS
Enteral Nutrition Formula™, the success of our
research and development, the results of the clinical evaluation
of Fortetropin® and its effects, the
ability to enter into new partnership opportunities and the success
of our existing partnerships, the ability to generate revenue and
cash flow from sales of our products, the ability to increase our
revenue and gross profit margins, the ability to achieve a
sustainable, profitable business, the effect of economic
conditions, the ability to protect our intellectual property
rights, competition from other providers and products, the
continued listing of our securities on the Nasdaq Stock Market,
risks in product development, our ability to raise capital to fund
continuing operations, and other factors discussed from time to
time in our filings with the Securities and Exchange
Commission. We undertake no obligation to update or revise any
forward-looking statement for events or circumstances after the
date on which such statement is made except as required by
law.
These statements have not been evaluated by the Food and Drug
Administration. Our products are not intended to diagnose, treat,
cure or prevent any disease.
Investor Relations:
Porter LeVay & Rose
Mathew Abenante, IRC, SVP
Phone: 212-564-4700
Email: MYOS@plrinvest.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/myos-rens-technology-to-exhibit-myos-canine-muscle-formula-at-the-new-york-vet-show-in-new-york-city-november-7--8-2019-300942427.html
SOURCE MYOS RENS Technology Inc.